Posted inBiotechnology
Novel circUBE2G1 Protein Inhibits Gastric Cancer Glycolysis
In a groundbreaking revelation that could alter the therapeutic landscape of gastric cancer, researchers have identified a novel protein encoded…
Posted inBiotechnology
Exploration Links Socioeconomic Gaps to Teen Learning
In the intricate tapestry of adolescent development, a groundbreaking study has shed unprecedented light on the intersection of exploration, socioeconomic…
Posted inBiotechnology
Synthetic Torpor: New Frontier in Metabolic Medicine
The natural world has long astounded scientists with its array of survival strategies, among which torpor stands out as a…
Posted inBiotechnology
Microbial Map Uncovers Hidden Links Between Food, Health, and the Planet for Healthier Food Systems
In an unprecedented synthesis of over 250 omics studies spanning horticulture, livestock farming, aquaculture, and food processing, researchers have unveiled…
Posted inBiotechnology
Synthetic Torpor: A Breakthrough Poised to Revolutionize Medicine
Inspiration gleaned from the natural world has long propelled scientific innovation, particularly in the realm of medicine and bioengineering. Over…
Posted inBiotechnology
Philanthropy Drives EMBL’s Strategy, Placing AI at Its Core
The European Molecular Biology Laboratory (EMBL) is poised to redefine the future of life sciences through an ambitious and comprehensive…
Posted inBiotechnology
Molecular Cell Atlas Unveils Mouse Lemur Biology
In a groundbreaking advance for primate biology and cellular genomics, researchers have unveiled a comprehensive molecular atlas of cell types…
Posted inBiotechnology
CD142+ Synovial Fibroblasts Fuel Meniscus Damage in RA
In a groundbreaking study published in Nature Communications, researchers have unveiled a pivotal role of CD142-positive synovial fibroblasts in the…
Posted inGenetics
Gut Bacteria Proteins Offer Clues to Chronic Disease Therapies
By analyzing proteins produced by gut bacteria, researchers from the University of Copenhagen and their collaborators elsewhere may have found…
Posted inBiotechnology
Nuvectis axes ovarian cancer program after seeing phase 1b data
Nuvectis Pharma has dropped plans to develop NXP800 in ovarian cancer after tallying two unconfirmed partial responses in a phase 1b…